Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis

Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Anthony, D, Sibson, N, Losey, P, Piani, D, Leppert, D
Formáid:	Conference item
Foilsithe / Cruthaithe:	2009

Míreanna comhchosúla

The antineoplastic properties of FTY720: Evidence for the repurposing of fingolimod
de réir: Patmanathan, S.N., et al.
Foilsithe / Cruthaithe: (2015)

Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model.
de réir: Anthony, D, et al.
Foilsithe / Cruthaithe: (2014)

The Immunosuppressant FTY720 (Fingolimod) enhances Glycosaminoglycan depletion in articular cartilage
de réir: Stradner Martin H, et al.
Foilsithe / Cruthaithe: (2011-12-01)

Ameliorative effects of Fingolimod (FTY720) on microglial activation and psychosis-related behavior in short term cuprizone exposed mice
de réir: Siyao Li, et al.
Foilsithe / Cruthaithe: (2023-07-01)

The Immunosuppressant Fingolimod (FTY720) for the Treatment of Mechanical Force-Induced Abnormal Scars
de réir: Masayo Aoki, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Fingolimod (FTY720) stimulates Ca(2+)/calcineurin signaling in fission yeast.
de réir: Kanako Hagihara, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Preclinical Metabolism, Pharmacokinetics and In Vivo Analysis of New Blood-Brain-Barrier Penetrant Fingolimod Analogues: FTY720-C2 and FTY720-Mitoxy.
de réir: Julius O Enoru, et al.
Foilsithe / Cruthaithe: (2016-01-01)

FTY720/fingolimod, a sphingosine analogue, reduces amyloid-β production in neurons.
de réir: Nobumasa Takasugi, et al.
Foilsithe / Cruthaithe: (2013-01-01)

FTY720-derivatives do not induce FTY720-like lymphopenia
de réir: Ismael Segura-Ulate, et al.
Foilsithe / Cruthaithe: (2017-03-01)

Behavioral Analyses in Dark Agouti Rats Following Repeated Systemic Treatment With Fingolimod (FTY720)
de réir: Marie Jakobs, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Effects of FTY720 (Fingolimod) on Proliferation, Differentiation, and Migration of Brain-Derived Neural Stem Cells
de réir: Botao Tan, et al.
Foilsithe / Cruthaithe: (2016-01-01)

FTY720 in hematopoietic cell transplantation FTY720 no transplante de células hematopoéticas
de réir: Valquiria Bueno
Foilsithe / Cruthaithe: (2008-01-01)

Effect of FTY720 (fingolimod) on graft survival in renal transplant recipients: a systematic review protocol
de réir: Reza Gholamnezhadjafari, et al.
Foilsithe / Cruthaithe: (2016-04-01)

The Effects of the S1P Receptor Agonist Fingolimod (FTY720) on Central and Peripheral Myelin in Twitcher Mice
de réir: Sibylle Béchet, et al.
Foilsithe / Cruthaithe: (2024-03-01)

Fingolimod (FTY720) Tedavisinin Relapsing-Remitting Multipl Skleroz Hastalarında Karaciğer Enzim Düzeylerine Etkisi
de réir: Duygu Tap, et al.
Foilsithe / Cruthaithe: (2020-12-01)

Fingolimod (FTY720) improves postoperative cognitive dysfunction in mice subjected to D-galactose-induced aging
de réir: Jie Zhang, et al.
Foilsithe / Cruthaithe: (2020-01-01)

In Vivo micro-PET Imaging Demonstrates Diminished Microglial Activation after FTY720 Treatment in an Animal Model of Multiple Sclerosis
de réir: Airas, L, et al.
Foilsithe / Cruthaithe: (2013)

Sphingosine 1-Phosphate Receptor Modulator Fingolimod (FTY720) Attenuates Myocardial Fibrosis in Post-heterotopic Heart Transplantation
de réir: Naseer Ahmed, et al.
Foilsithe / Cruthaithe: (2017-09-01)

FTY720/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice
de réir: Timothy D. Rohrbach, et al.
Foilsithe / Cruthaithe: (2019-07-01)

Fingolimod (FTY720), a Sphinogosine-1-Phosphate Receptor Agonist, Mitigates Choroidal Endothelial Proangiogenic Properties and Choroidal Neovascularization
de réir: Christine M. Sorenson, et al.
Foilsithe / Cruthaithe: (2022-03-01)

Immunomodulatory drug fingolimod (FTY720) restricts the growth of opportunistic yeast Candida albicans in vitro and in a mouse candidiasis model.
de réir: Niloofar Najarzadegan, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Immunomodulatory drug fingolimod (FTY720) restricts the growth of opportunistic yeast Candida albicans in vitro and in a mouse candidiasis model
de réir: Niloofar Najarzadegan, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Therapeutic approach to mite-induced intractable dermatitis using novel immunomodulator FTY720 ointment (fingolimod) in NC/Nga mice
de réir: Takumi Tsuji, et al.
Foilsithe / Cruthaithe: (2016-04-01)

Erratum: FTY720/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice
de réir: Timothy D. Rohrbach, et al.
Foilsithe / Cruthaithe: (2020-02-01)

The Therapeutic Targets of Fingolimod (FTY720) Are Involved in Pathological Processes in the Frontal Cortex of Alzheimer's Disease Patients: A Network Pharmacology Study
de réir: Pengqi Yin, et al.
Foilsithe / Cruthaithe: (2021-02-01)

Sphingomimetic multiple sclerosis drug FTY720 activates vesicular synaptobrevin and augments neuroendocrine secretion
de réir: Frederic D. Darios, et al.
Foilsithe / Cruthaithe: (2017-07-01)

FTY720 Inhibits the Development of Collagen-Induced Arthritis in Mice by Suppressing the Recruitment of CD4+ T Lymphocytes
de réir: Zhu C, et al.
Foilsithe / Cruthaithe: (2021-05-01)

Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis
de réir: Kathrin Bail, et al.
Foilsithe / Cruthaithe: (2017-07-01)

FTY720/fingolimod increases NPC1 and NPC2 expression and reduces cholesterol and sphingolipid accumulation in Niemann-Pick type C mutant fibroblasts
de réir: Newton, J, et al.
Foilsithe / Cruthaithe: (2017)

Pharmacokinetic/pharmacodynamic relationships of FTY720 in kidney transplant recipients
de réir: S.I. Park, et al.
Foilsithe / Cruthaithe: (2005-05-01)

Effect of a New Immunosuppressive Agent, Fty720, on Survival of Islet Allografts
de réir: Toru Yamasaki, et al.
Foilsithe / Cruthaithe: (1998-07-01)

Effect of FTY720P on lipid accumulation in HEPG2 cells
de réir: Reem Rida, et al.
Foilsithe / Cruthaithe: (2023-11-01)

The protective role of FTY720 in promoting survival of allograft fat in mice
de réir: Yi Yi, et al.
Foilsithe / Cruthaithe: (2022-09-01)

Lymphocyte modulation with FTY720 improves hemorrhagic shock survival in swine.
de réir: Jason S Hawksworth, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Metformin and FTY720 Synergistically Induce Apoptosis in Multiple Myeloma Cells
de réir: Yi Zhao, et al.
Foilsithe / Cruthaithe: (2018-07-01)

Effects of FTY720 on Lung Injury Induced by Hindlimb Ischemia Reperfusion in Rats
de réir: Liangrong Wang, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Anti-tumor drug FTY720 regulates p53-dependent transcription
de réir: YAO Han, XU Wen-bin, WANG Dong-lai
Foilsithe / Cruthaithe: (2021-03-01)

Increased semi-allogeneic skin graft survival after FTY720 treatment
de réir: Priscilla Carnavale Gomes Ferreira, et al.
Foilsithe / Cruthaithe: (2008-09-01)

New building blocks for convenient access to positional isomers of FTY720 and analogues
de réir: Santosh R. Borkar, et al.
Foilsithe / Cruthaithe: (2015-11-01)

Are different degrees of lymphopenia for FTY720 associated with serious infectious-type events? No
de réir: Catalina Márquez-Martín, et al.
Foilsithe / Cruthaithe: (2022-07-01)